These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
317 related items for PubMed ID: 3511581
1. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine. Canafax DM, Torres A, Fryd DS, Heil JE, Strand MH, Ascher NL, Payne WD, Sutherland DE, Simmons RL, Najarian JS. Transplantation; 1986 Feb; 41(2):177-81. PubMed ID: 3511581 [Abstract] [Full Text] [Related]
2. Detrimental effect of cyclosporine on initial function of cadaver renal allografts following extended preservation. Results of a randomized prospective study. Novick AC, Hwei HH, Steinmuller D, Streem SB, Cunningham RJ, Steinhilber D, Goormastic M, Buszta C. Transplantation; 1986 Aug; 42(2):154-8. PubMed ID: 3526655 [Abstract] [Full Text] [Related]
4. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years. Johnson CP, Simmons RL, Sutherland DE, Canafax DM, Ascher NL, Payne WD, Flick B, Najarian JS, Fryd DS. Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431 [Abstract] [Full Text] [Related]
5. A prospective randomized comparison of quadruple versus triple therapy for first cadaver transplants with immediate function. Slakey DP, Johnson CP, Callaluce RD, Browne BJ, Zhu YR, Roza AM, Adams MB. Transplantation; 1993 Oct; 56(4):827-31. PubMed ID: 8212201 [Abstract] [Full Text] [Related]
6. Individualization of immediate posttransplant immunosuppression. The value of antilymphocyte globulin in patients with delayed graft function. Matas AJ, Tellis VA, Quinn TA, Glicklich D, Soberman R, Veith FJ. Transplantation; 1988 Feb; 45(2):406-9. PubMed ID: 3278434 [Abstract] [Full Text] [Related]
7. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Najarian JS, Fryd DS, Strand M, Canafax DM, Ascher NL, Payne WD, Simmons RL, Sutherland DE. Ann Surg; 1985 Feb; 201(2):142-57. PubMed ID: 3882063 [Abstract] [Full Text] [Related]
8. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Boudreaux JP, McHugh L, Canafax DM, Ascher N, Sutherland DE, Payne W, Simmons RL, Najarian JS, Fryd DS. Transplantation; 1987 Sep; 44(3):376-81. PubMed ID: 3307061 [Abstract] [Full Text] [Related]
9. A comparison of the effects of cyclosporine versus antilymphocyte globulin on delayed graft function in cadaver renal transplant recipients. Michael HJ, Francos GC, Burke JF, Besarab A, Moritz M, Gillum D, Jarrell B. Transplantation; 1989 Nov; 48(5):805-8. PubMed ID: 2683263 [Abstract] [Full Text] [Related]
10. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation. Clark G, Walsh G, Deshpande P, Koffman G. Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256 [Abstract] [Full Text] [Related]
11. Effect of cyclosporine and delayed graft function on posttransplantation erythropoiesis. Besarab A, Caro J, Jarrell B, Burke J, Francos G, Mallon E, Karsch R. Transplantation; 1985 Dec; 40(6):624-31. PubMed ID: 3907033 [Abstract] [Full Text] [Related]
12. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years. Canadian Multicentre Transplant Study Group. N Engl J Med; 1986 May 08; 314(19):1219-25. PubMed ID: 2871486 [Abstract] [Full Text] [Related]
13. Post-transplant acute renal failure in cadaver renal recipients treated with cyclosporine. Hall BM, Tiller DJ, Duggin GG, Horvath JS, Farnsworth A, May J, Johnson JR, Sheil AG. Kidney Int; 1985 Aug 08; 28(2):178-86. PubMed ID: 3914572 [Abstract] [Full Text] [Related]
15. Sequential antilymphocyte globulin/cyclosporine immunosuppression in cadaveric renal transplantation. Effect of duration of ALG therapy. Stratta RJ, D'Alessandro AM, Armbrust MJ, Pirsch JD, Sollinger HW, Kalayoglu M, Belzer FO. Transplantation; 1989 Jan 08; 47(1):96-102. PubMed ID: 2643236 [Abstract] [Full Text] [Related]
16. Sequential antilymphoblast globulin and cyclosporine for renal transplantation. Sommer BG, Henry M, Ferguson RM. Transplantation; 1987 Jan 08; 43(1):85-90. PubMed ID: 3541330 [Abstract] [Full Text] [Related]
17. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone. Barnhart GR, Goldman MH, Hastillo A, Szentpetery S, Wolfgang T, Thompson J, Mohanakumar T, Katz MR, Rider S, Hanrahan J. J Heart Transplant; 1985 Jan 08; 4(4):381-4. PubMed ID: 3916511 [Abstract] [Full Text] [Related]
18. A controlled randomized double-blind study of antilymphoblast globulin in cadaver renal transplantation. Novick AC, Braun WE, Steinmuller D, Buszta C, Greenstreet R, Kiser W. Transplantation; 1983 Feb 08; 35(2):175-9. PubMed ID: 6338636 [Abstract] [Full Text] [Related]
19. Antilymphocyte globulin with a small dose of cyclosporine A and prednisone as the induction of immunosuppression in renal allograft recipients. Boratyńska M, Szepietowski T, Szewczyk Z, Szydłowski Z. Arch Immunol Ther Exp (Warsz); 1992 Feb 08; 40(2):163-8. PubMed ID: 1299176 [Abstract] [Full Text] [Related]
20. Thromboembolic complications in renal allograft recipients. A report from the prospective randomized study of cyclosporine versus azathioprine-antilymphocyte globulin. Gruber SA, Pescovitz MD, Simmons RL, Najarian JS, Ascher NL, Payne WD, Sutherland DE, Fryd DS. Transplantation; 1987 Dec 08; 44(6):775-8. PubMed ID: 3321586 [Abstract] [Full Text] [Related] Page: [Next] [New Search]